Completed NA INTERVENTIONAL 2-arm NCT04305756

Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery

Sponsor: University of Utah

Conditions Postpartum DVT Thromboembolism Thrombosis

Interventions Enoxaparin

Updated 8 times since 2020 Last updated: Jan 26, 2022 Started: Jun 12, 2020 Primary completion: Dec 15, 2021 Completion: Dec 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Postpartum DVT and Thromboembolism and is currently completed. University of Utah leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Dec 2021 — Feb 2022 [monthly]

Recruiting NA
May 2021 — Dec 2021 [monthly]

Recruiting NA

▶ Show 3 earlier versions

Jan 2021 — May 2021 [monthly]

Recruiting NA
Jul 2020 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Apr 2020 — Jul 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Utah

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States